FY2020

Kilitch Drugs Issues an Advisory for Improved Financial Performance in FY2020, Driven by Recovering Sudanese Market

Mumbai, August 17, 2019: Kilitch Drugs (India) Ltd., (BSE: 524500 / NSE: KILITCH / ISIN: INE729D01010), a Mumbai based company…

5 years ago

Kilitch Drugs (India) records a robust growth in Q2FY19

Net Sales up (YoY) to Rs. 26.72 crore Registers a net profit of Rs.4.49 crore EPS for the second quarter…

6 years ago